MMedication Read More Wegovy And Zepbound Cost Effective But They Could Break Drug BudgetsSeptember 11, 2025 The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative…
MMedication Read More Pricing group says weight-loss drugs becoming more cost-effectiveSeptember 9, 2025 By Deena Beasley (Reuters) -An influential drug pricing watchdog on Tuesday said popular GLP-1 weight-loss injections have become…
MMedication Read More GLP-1 drugs and vision loss: How significant are the risks? – Medical News TodayAugust 21, 2025 GLP-1 drugs and vision loss: How significant are the risks? Medical News Today From stomach paralysis to vision loss:…
MMedication Read More Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosisAugust 18, 2025 “Today’s decision by the FDA reflects the continued progress in how we understand and treat patients with MASH,…
MMedication Read More Thousands of Ozempic scripts written for under-18s, data showJuly 10, 2025 Under-18s are receiving scripts for the blockbuster semaglutide drug Ozempic despite it not being TGA-approved for children or…
MMedication Read More The weight loss drug market has gotten messy. What to know.June 26, 2025 Earlier this week, Novo Nordisk tore up a partnership with the telehealth storefront Hims & Hers Health, which had…